Letter: infliximab therapy for patients with inflammatory bowel disease--some unanswered questions. Authors' reply.

Buurman, D J; Maurer, J M; Keizer, R J; Kosterink, J G W; Dijkstra, G

Buurman, D J; Maurer, J M; Keizer, R J; Kosterink, J G W; Dijkstra, G.

Afiliación

Buurman DJ; Department of Gastroenterology and Hepatology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands. d.buurman@umcg.nl.
Maurer JM; Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Keizer RJ; Department of Bioengineering and Therapeutic Sciences, School of Pharmacy, University of California San Francisco, San Francisco, CA, USA.
Kosterink JG; Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Dijkstra G; Department of Pharmacy, Section Pharmacotherapy and Pharmaceutical Care, University of Groningen, Groningen, The Netherlands.

Aliment Pharmacol Ther ; 42(9): 1134, 2015 Nov.

Article en En | MEDLINE | ID: mdl-26427756

Asunto(s)

Fármacos Gastrointestinales/farmacocinética; Fármacos Gastrointestinales/uso terapéutico; Enfermedades Inflamatorias del Intestino/tratamiento farmacológico; Infliximab/farmacocinética; Infliximab/uso terapéutico; Femenino; Humanos; Masculino

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Fármacos Gastrointestinales / Enfermedades Inflamatorias del Intestino / Infliximab Límite: Female / Humans / Male Idioma: En Revista: Aliment Pharmacol Ther Asunto de la revista: FARMACOLOGIA / GASTROENTEROLOGIA / TERAPIA POR MEDICAMENTOS Año: 2015 Tipo del documento: Article País de afiliación: Países Bajos Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google